Literature DB >> 19337059

Tobacco abuse relates to significantly reduced survival of patients with oropharyngeal carcinomas.

Eva Hilgert1, Christoph Bergmann, Alexander Fichtner, Olivier Gires, Wolfgang Issing.   

Abstract

This study represents an in-depth evaluation of the impact of smoking and alcohol consumption on patients' outcome in 809 cases of oropharyngeal carcinoma. Prognostic parameters and additional information such as smoking and drinking habits were evaluated referring to the patients' case notes at the time point of first diagnosis. The overall 10-year survival rate was 45.5%, whereas 33.4% of the patients remained relapse-free. The great majority (92%) of patients had a history of smoking or were current smokers, whereas only 8% of the collective never smoked in their lifetime. Interestingly, we found a significant reduction of 10-year survival rates for smokers (28.8%) in comparison with nonsmokers (43.1%) and ex-smokers (P=0.0007). This study presents data from a large cohort of patients with oropharyngeal carcinoma providing evidence for a relationship between alcohol and tobacco consumption, and significantly worse prognosis.

Entities:  

Mesh:

Year:  2009        PMID: 19337059     DOI: 10.1097/CEJ.0b013e32831012a4

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  6 in total

1.  Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy.

Authors:  Davide Franceschini; Fabiola Paiar; Calogero Saieva; Pierluigi Bonomo; Benedetta Agresti; Icro Meattini; Daniela Greto; Monica Mangoni; Fiammetta Meacci; Mauro Loi; Giacomo Zei; Lorenzo Livi; Giampaolo Biti
Journal:  Radiol Med       Date:  2015-09-24       Impact factor: 3.469

2.  Current-Smoking-Related COPD or COPD With Acute Exacerbation is Associated With Poorer Survival Following Oral Cavity Squamous Cell Carcinoma Surgery.

Authors:  Jiaqiang Zhang; Wei-Chun Lin; Kuo-Chin Chiu; Szu-Yuan Wu
Journal:  Chronic Obstr Pulm Dis       Date:  2022-04-29

3.  Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomas.

Authors:  Christoph Bergmann; Hagen S Bachmann; Agnes Bankfalvi; Ramin Lotfi; Carolin Pütter; Clarissa A Wild; Patrick J Schuler; Jens Greve; Thomas K Hoffmann; Stephan Lang; André Scherag; Götz F Lehnerdt
Journal:  J Transl Med       Date:  2011-08-21       Impact factor: 5.531

4.  Relationship between HPV and the biomarkers annexin A1 and p53 in oropharyngeal cancer.

Authors:  Cleberson Jean Dos Santos Queiroz; Cíntia Mara de Amorim Gomes Nakata; Egle Solito; Amílcar Sabino Damazo
Journal:  Infect Agent Cancer       Date:  2014-04-21       Impact factor: 2.965

5.  Epigenetic prediction of complex traits and mortality in a cohort of individuals with oropharyngeal cancer.

Authors:  Ryan J Langdon; Rhona A Beynon; Kate Ingarfield; Riccardo E Marioni; Daniel L McCartney; Richard M Martin; Andy R Ness; Michael Pawlita; Tim Waterboer; Caroline Relton; Steven J Thomas; Rebecca C Richmond
Journal:  Clin Epigenetics       Date:  2020-04-22       Impact factor: 6.551

6.  Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.

Authors:  Géraldine Descamps; Yasemin Karaca; Jérôme R Lechien; Nadège Kindt; Christine Decaestecker; Myriam Remmelink; Denis Larsimont; Guy Andry; Samantha Hassid; Alexandra Rodriguez; Mohammad Khalife; Fabrice Journe; Sven Saussez
Journal:  J Cancer Res Clin Oncol       Date:  2016-07-01       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.